JEANNE SALADA-CONROY: Open Payments
NPI 1073518668 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,165 in 117 payments from 17 companies in 2025. Trend: 2023 $2,354 · 2024 $2,725 · 2025 $2,165
Food & beverage: $2,165
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $321 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $282 |
| Otsuka America Pharmaceutical, Inc. | 18 | $250 |
| Lundbeck LLC | 13 | $187 |
| E.R. Squibb & Sons, L.L.C. | 3 | $175 |
| ABBVIE INC. | 10 | $161 |
| Vanda Pharmaceuticals Inc. | 6 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $147 |
| Teva Pharmaceuticals USA, Inc. | 6 | $141 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
Products named: REXULTI, INGREZZA, CAPLYTA, COBENFY, VRAYLAR, TRINTELLIX, AUSTEDO XR, FANAPT.
Industry payments across NY — which companies pay providers there.
